Analyst Ratings for Emergent Biosolutions Inc. (EBS)

Updated: 2017-07-27

Analysts covering Emergent Biosolutions Inc. (NYSE:EBS) have given it a consensus rating of Buy. A consensus rating of Buy was previously issued for EBS last month.

A buy rating was issued by 5 analysts, 0 gave an overweight rating, 1 gave a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

EBS was given price targets by several analysts. The most optimistic price target was 50, implying potential capital gains of 38.7 percent. The most pessimistic price target was 33, implying potential capital losses of -8.46 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 0 percent. That number becomes -33.43 percent if we expand the time horizon to include the past 3 months instead of just one. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. If we look at the last 90 days instead, we find a net average change of 4.29 percent in FY estimates.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.

The growth rate of EBS's earnings is estimated by analysts to be 27.19 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of EBS is 1.11.

In the trailing 52-weeks, EBS hit 36.64 at the highest peak, while it's lowest trading point was 24.47. The current market price is above the trailing year's low by 47.32 percent, and 1.61 percent lower than its 52-week high. EBS has a price/earnings ratio of 30.31. Investors typically compare the P/E ratio to a company's peers in the industry. The EBS value stock report compares EBS to some of its peers using value stock charts. The market cap of EBS is $1.48 billion. EBS is estimated to release their earnings results for the quarter on 0000-00-00, days from today.